News & Events

Filter Year   Keywords   > Submit

Page 1 3

KaloBios Provides Update on Pipeline of Clinical Programs

28 / 06 / 2013

KaloBios Pharmaceuticals, Inc. (Nasdaq: KBIO) today provided an update on the status of its ongoing clinical programs for KB003, KB001-A and KB004, its pipeline of proprietary monoclonal antibodies in development for severe respiratory diseases and cancer.

> Read More

Sunshine Heart Announces Corporate Updates and First Quarter 2013 Financial Results

14 / 05 / 2013

EDEN PRAIRIE, Minn., May 14, 2013 (GLOBE NEWSWIRE) -- Sunshine Heart, Inc. (Nasdaq:SSH) today announced corporate updates and financial results for the first quarter ended March 31, 2013.

> Read More

World-First Study Predicts Epilepsy Seizures in Humans

07 / 05 / 2013

A small device implanted in the brain has accurately predicted epilepsy seizures in humans in a world-first study led by Professor Mark Cook, Chair of Medicine at the University of Melbourne and Director of Neurology at St Vincent's Hospital.

> Read More

Neuromonics Unveils New Device to Relieve Mild, Moderate Tinnitus at Audiology NOW!

28 / 03 / 2013

â?? Neuromonics Sanctuaryâ?¢ provides on-demand tinnitus relief â??

> Read More

APPLIED PHYSIOLOGY® Receives key US Patent Award for its Unique NAVIGATOR� Technology

22 / 03 / 2013

Applied Physiology® Pty Ltd today announced that the U.S. Patent and Trademark Office has awarded a key patent for its unique Navigator� technology for clinical decision support of circulatory management.

> Read More


19 / 02 / 2013

Cambridge, MA â?? February 19, 2013 â?? Neurovance, Inc. today announced that the United States Patent and Trademark Office (USPTO) has issued a notice of allowance for a composition of matter patent for EB-1020. The patent provides Neurovance with proprietary protection for EB-1020 through July 2026.

> Read More

KaloBios Pharmaceuticals Completes Initial Public Offering

08 / 02 / 2013

KaloBios Pharmaceuticals, Inc. (NASDAQ:KBIO) today announced the completion of its initial public offering of 8,750,000 shares of common stock at $8.00 per share.

> Read More

Sunshine Heart Appoints Warren Watson to Board of Directors

30 / 01 / 2013

Seasoned Leader in Cardiology Joins as Director Replacing William Peters

> Read More

Displaying records 26-50 of 56